CLOs on the Move

Moran Vista Assisted Living

www.moranvista.com

 
Moran Vista Assisted Living is a Spokane, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Community Health Action of Staten Island

In 1988, a group of advocates, providers, and consumers created the Staten Island AIDS Task Force in response to the health crisis of HIV and AIDS in our community. For many years, the Task Force was the only non-profit community-based organization who...

CHEO Research Institute

Discoveries to inspire the best life for every child and youth. The CHEO Research Institute is a not for profit corporation that connects exceptional talent and technology in pursuit of life-changing research for every child, youth and family in our community and beyond. We inspire trust in our research excellence by being curious, nimble, passionate and equitable.

AOSpine North America

AOSpine North America is a Paoli, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

DispatchHealth

DispatchHealth is redefining healthcare delivery through the most advanced on-demand, in-home healthcare model in the country. Our board-certified medical teams can treat common to complex injuries and illnesses in the comfort of your home.

Berg LLC

BERG is a Boston-based biopharma company focused on taking a bold “back to biology” approach to therapeutic discovery using its unique AI-based Interrogative Biology® platform. This platform combines patient biology and AI-based analytics to engage the differences between healthy and disease environments. The patient’s own biology drives the platform’s results and guides us in the discovery and development of drugs, diagnostics and healthcare applications. Our platform utilizes patient population health data to bring actionable Patient IntelligenceTM to precision medicine applications. For patients this means faster discovery and development of treatments, more effective precision treatments for individuals as well as a reduction in costs to our healthcare systems. BERG has a robust product portfolio in oncology, endocrinology and neurology with mature assets in oncology entering mid and late stage trials. BERG is committed to improving the lives of patients through precision medicine made possible by our innovative platforms.